- Home
- TLX vs PLXS Comparison
TLX vs PLXS Comparison
Compare TLX & PLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- PLXS
- Stock Information
- Founded
- TLX 2015
- PLXS 1979
- Country
- TLX Australia
- PLXS United States
- Employees
- TLX N/A
- PLXS N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- PLXS Electrical Products
- Sector
- TLX Health Care
- PLXS Technology
- Exchange
- TLX Nasdaq
- PLXS Nasdaq
- Market Cap
- TLX 4.0B
- PLXS 3.7B
- IPO Year
- TLX N/A
- PLXS 1986
- Fundamental
- Price
- TLX $9.51
- PLXS $137.01
- Analyst Decision
- TLX Strong Buy
- PLXS Strong Buy
- Analyst Count
- TLX 3
- PLXS 5
- Target Price
- TLX $22.33
- PLXS $154.50
- AVG Volume (30 Days)
- TLX 217.0K
- PLXS 137.6K
- Earning Date
- TLX 01-01-0001
- PLXS 10-22-2025
- Dividend Yield
- TLX N/A
- PLXS N/A
- EPS Growth
- TLX N/A
- PLXS 47.80
- EPS
- TLX 0.04
- PLXS 5.87
- Revenue
- TLX $664,225,558.00
- PLXS $4,025,169,000.00
- Revenue This Year
- TLX N/A
- PLXS $3.54
- Revenue Next Year
- TLX N/A
- PLXS $8.05
- P/E Ratio
- TLX $298.01
- PLXS $23.34
- Revenue Growth
- TLX 55.35
- PLXS 2.31
- 52 Week Low
- TLX $9.48
- PLXS $103.43
- 52 Week High
- TLX $30.36
- PLXS $172.89
- Technical
- Relative Strength Index (RSI)
- TLX 31.15
- PLXS 56.97
- Support Level
- TLX $12.12
- PLXS $126.86
- Resistance Level
- TLX $12.58
- PLXS $139.01
- Average True Range (ATR)
- TLX 0.45
- PLXS 3.20
- MACD
- TLX 0.01
- PLXS 0.90
- Stochastic Oscillator
- TLX 0.98
- PLXS 77.19
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About PLXS Plexus Corp.
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.